Clinical Trials Browser

Adenoviridae Infections, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03159364 2019-09-19

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Phase 1/2 Unknown

100 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Mycoses, Tuberculosis, Epstein-Barr Virus Infections

NCT02894944 2019-09-12

Theragene

Phase 1 Completed

9 enrolled

Gastrointestinal

Adenoviridae Infections, Pancreatic Neoplasms

NCT03029871 2019-08-13

NSCLC

Phase 1 Withdrawn

Thoracic

Adenoviridae Infections, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03190824 2019-04-16

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Phase 2 Unknown

4 enrolled

Dermatologic

Adenoviridae Infections, Melanoma

NCT00372320 2018-09-11

Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

Phase 1 Completed

17 enrolled

Head & Neck

Adenoviridae Infections, Head and Neck Neoplasms, Xerostomia

NCT02654938 2017-09-20

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Phase 1 Completed

32 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT02844699 2017-09-20

A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Phase 1/2 Unknown

24 enrolled

Genitourinary

Alzheimer Disease 5, Adenoviridae Infections, Prostatic Neoplasms

NCT01864759 2017-08-29

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

Phase 1 Completed

14 enrolled

Dermatologic

Adenoviridae Infections, Melanoma, Neoplasm Metastasis

NCT00711035 2016-04-26

CHALLAH

Phase 1/2 Completed

50 enrolled

Adenoviridae Infections, Epstein-Barr Virus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

10 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00625430 2011-07-11

FP253-GDEPT

Phase 1 Unknown

18 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT00109655 2008-10-03

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Phase 1 Unknown

75 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT00116363 2008-04-01

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Phase 2 Unknown

25 enrolled

Dermatologic

Adenoviridae Infections, Melanoma, Neoplasm Metastasis

NCT00262327 2006-06-20

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Phase 1 Unknown

20 enrolled

Adenoviridae Infections, Neoplasms

Clinical Trials

TUNIMO

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

VSTs

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

PROTA

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

TRACE

Gamma Capture

ACES

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

CEDAR

R-MVST Cells for Treatment of Viral Infections

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Prevent

Prevent

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

AdUP

ACE

CHARMS

BOND

An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Theragene

NSCLC

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

CHALLAH

VIRAGE

FP253-GDEPT

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor